![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Multiple Sclerosis |
Free Subscription
4 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Multiple Sclerosis is free of charge.
Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a
prospective observational study.
BMC Neurol. 2022;22:479.
PubMed
Abstract available
Strengthening the occupational and social participation of multiple sclerosis
patients - design of a multicenter, parallel-group randomized controlled trial
(MSnetWork-study).
BMC Neurol. 2022;22:472.
PubMed
Abstract available
The barriers and facilitators to health-promoting lifestyle behaviors among
people with multiple sclerosis during the coronavirus disease 2019 pandemic: a
content analysis study.
BMC Neurol. 2022;22:490.
PubMed
Abstract available
Magnetic resonance imaging negative myelopathy in Leber's hereditary optic
neuropathy: a case report.
BMC Neurol. 2022;22:487.
PubMed
Abstract available
Anterior optic pathway pathology in CNS demyelinating diseases.
Brain. 2022;145:4308-4319.
PubMed
Abstract available
Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and
neurodegeneration.
Brain. 2022;145:4287-4307.
PubMed
Abstract available
A novel eye-movement impairment in multiple sclerosis indicating wide-spread
cortical damage.
Brain. 2022 Dec 20:awac474. doi: 10.1093.
PubMed
Abstract available
Importance of Identifying Cognitive Impairment in Multiple Sclerosis.
Can J Neurol Sci. 2022 Dec 12:1-23. doi: 10.1017/cjn.2022.
PubMed
Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing
multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS).
J Neuroimmunol. 2022;374:578008.
PubMed
Abstract available
Validity of serum neurofilament light chain as a prognostic biomarker of disease
activity in multiple sclerosis.
J Neurol. 2022 Dec 15. doi: 10.1007/s00415-022-11507.
PubMed
Abstract available
The insula modulates the effects of aerobic training on cardiovascular function
and ambulation in multiple sclerosis.
J Neurol. 2022 Dec 12:1-10. doi: 10.1007/s00415-022-11513.
PubMed
Abstract available
Adipokines in multiple sclerosis patients are related to clinical and
radiological measures.
J Neurol. 2022 Dec 23. doi: 10.1007/s00415-022-11519.
PubMed
Abstract available
Longitudinal characterisation of B and T-cell immune responses after the booster
dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different
disease-modifying therapies.
J Neurol Neurosurg Psychiatry. 2022 Dec 15:jnnp-2022-330175.
PubMed
Abstract available
Effect of multiple sclerosis disease-modifying therapies on the real-world
effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine.
J Neurol Sci. 2022;444:120518.
PubMed
Abstract available
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and
treatment.
Lancet Neurol. 2022 Sep 22. pii: S1474-4422(22)00187.
PubMed
Abstract available
Multiple sclerosis in 2022: old players, new insights.
Lancet Neurol. 2023;22:19-21.
PubMed
Association of paramagnetic rim lesions and retinal layer thickness in patients
with multiple sclerosis.
Mult Scler. 2022 Dec 20:13524585221138486. doi: 10.1177/13524585221138486.
PubMed
Abstract available
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple
sclerosis: A consensus statement.
Mult Scler. 2022 Dec 17:13524585221134217. doi: 10.1177/13524585221134217.
PubMed
Abstract available
Magnetization transfer saturation reveals subclinical optic nerve injury in
pediatric-onset multiple sclerosis.
Mult Scler. 2022 Dec 22:13524585221137500. doi: 10.1177/13524585221137500.
PubMed
Abstract available
Improvement in time to multiple sclerosis diagnosis: 25-year retrospective
analysis from New York State MS Consortium (NYSMSC).
Mult Scler. 2022 Dec 22:13524585221140271. doi: 10.1177/13524585221140271.
PubMed
Abstract available
Anterior horn atrophy in the cervical spinal cord: A new biomarker in progressive
multiple sclerosis.
Mult Scler. 2022 Dec 22:13524585221139152. doi: 10.1177/13524585221139152.
PubMed
Abstract available
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient
preference data to the OPTIMUM trial.
Mult Scler. 2022 Dec 22:13524585221140270. doi: 10.1177/13524585221140270.
PubMed
Abstract available
Selective vulnerability of brainstem and cervical spinal cord regions in people
with non-progressive multiple sclerosis of Black or African American and European
ancestry.
Mult Scler. 2022 Dec 12:13524585221139575. doi: 10.1177/13524585221139575.
PubMed
Abstract available
Is the central vein sign a useful diagnostic marker for paediatric-onset multiple
sclerosis?
Mult Scler. 2022 Dec 13:13524585221142318. doi: 10.1177/13524585221142318.
PubMed
Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case
series study.
Mult Scler. 2022 Dec 13:13524585221142319. doi: 10.1177/13524585221142319.
PubMed
Abstract available
A role for HLA in mediating long-term multiple sclerosis outcomes?
Mult Scler. 2022 Dec 14:13524585221139767. doi: 10.1177/13524585221139767.
PubMed
It is time to define cognitive phenotypes in multiple sclerosis.
Mult Scler. 2022 Dec 14:13524585221141263. doi: 10.1177/13524585221141263.
PubMed
Improving the decision to switch from first- to second-line therapy in multiple
sclerosis: A dynamic scoring system.
Mult Scler. 2022 Dec 14:13524585221139156. doi: 10.1177/13524585221139156.
PubMed
Abstract available
Relationship between paramagnetic rim lesions and slowly expanding lesions in
multiple sclerosis.
Mult Scler. 2022 Dec 14:13524585221141964. doi: 10.1177/13524585221141964.
PubMed
Abstract available
Telemedicine Utilization Among Patients With Multiple Sclerosis in the US
Veterans Health Administration, 2010-2020.
Neurol Clin Pract. 2022;12:e133-e142.
PubMed
Abstract available
Association of Choroid Plexus Inflammation on MRI With Clinical Disability
Progression Over 5 Years in Patients With Multiple Sclerosis.
Neurology. 2022 Dec 21:10.1212/WNL.0000000000201608.
PubMed
Abstract available
Hematopoietic Stem Cell Transplantation in People With Active Secondary
Progressive Multiple Sclerosis.
Neurology. 2022 Dec 21:10.1212/WNL.0000000000206750.
PubMed
Abstract available
Understanding the Role of the Choroid Plexus in Multiple Sclerosis as an MRI
Biomarker of Disease Activity.
Neurology. 2022 Dec 21:10.1212/WNL.0000000000206806.
PubMed
Complicated Monkeypox Infection in a Patient With Multiple Sclerosis and
Fingolimod Treatment.
Neurology. 2022 Dec 20:10.1212/WNL.0000000000206743.
PubMed
Differential transcriptomic changes in the central nervous system and urinary
bladders of mice infected with a coronavirus.
PLoS One. 2022;17:e0278918.
PubMed
Abstract available
Mitochondrial DNA haplogroup analysis in Saudi Arab patients with multiple
sclerosis.
PLoS One. 2022;17:e0279237.
PubMed
Abstract available
Serology results after COVID vaccine in multiple sclerosis patients treated with
fingolimod.
Rev Neurol (Paris). 2022 Dec 7:S0035-3787(22)00824.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by